tiprankstipranks
Hikma Pharmaceuticals PLC (HKMPY)
OTHER OTC:HKMPY
US Market
HKMPY
Hikma Pharmaceuticals
RESEARCH TOOLSreports

Hikma Pharmaceuticals (HKMPY) Income Statement

44 Followers

Hikma Pharmaceuticals Income Statement

Last quarter (Q4 2025), Hikma Pharmaceuticals's total revenue was $1.68B, an increase of 17.28% from the same quarter last year. In Q4, Hikma Pharmaceuticals's net income was $163.39M. See Hikma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.36B$ 3.13B$ 2.88B$ 2.52B$ 2.55B
Gross Profit
$ 1.34B$ 1.42B$ 1.41B$ 1.24B$ 1.30B
Operating Expenses
$ 718.68M$ 803.00M$ 1.04B$ 956.00M$ 719.00M
Depreciation and Amortization
$ 212.50M$ 197.00M$ 191.00M$ 190.00M$ 167.00M
EBITDA
$ 837.95M$ 727.00M$ 559.00M$ 688.00M$ 766.00M
Operating Income
$ 625.46M$ 612.00M$ 367.00M$ 282.00M$ 582.00M
Other Income/Expenses
$ -105.25M$ -158.00M$ -86.00M$ -49.00M$ -39.00M
Pretax Income
$ 520.21M$ 454.00M$ 281.00M$ 233.00M$ 543.00M
Net Income
$ 402.94M$ 359.00M$ 190.00M$ 188.00M$ 421.00M
Per Share Metrics
Basic EPS
$ 3.66$ 3.24$ 1.70$ 1.68$ 3.64
Diluted EPS
$ 3.62$ 3.22$ 1.72$ 1.68$ 3.62
Weighted Average Shares Outstanding
 110.29M 110.67M 111.18M 111.86M 115.50M
Weighted Average Shares Outstanding (Diluted)
 111.34M 111.75M 111.18M 112.50M 116.50M
Currency in USD

Hikma Pharmaceuticals Earnings and Revenue History